Accuray Incorporated Cost of Revenue 2011-2026 | ARAY

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue Accuray Incorporated

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
312 M	304 M	294 M	270 M	237 M	233 M	256 M	243 M	242 M	240 M	234 M	227 M	218 M	272 M	115 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
312 M	115 M	246 M

Quarterly Cost of Revenue Accuray Incorporated

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
78.2 M	67.4 M	-	81.6 M	74.3 M	67.1 M	-	72.1 M	71.3 M	64.4 M	-	79.3 M	71.8 M	61.9 M	134 M	61.4 M	73.6 M	67.9 M	142 M	63 M	56.6 M	49.9 M	56.6 M	49.9 M	60.9 M	56.6 M	60.9 M	56.6 M	63.9 M	58 M	63.9 M	58 M	61 M	52.8 M	61 M	52.8 M	56.1 M	55.2 M	56.1 M	55.2 M	66.3 M	55.7 M	66.3 M	55.7 M	59.7 M	54.6 M	59.7 M	54.6 M	55.5 M	50.2 M	55.5 M	50.2 M	51.2 M	59.1 M	51.2 M	59.1 M	66.2 M	76 M	66.2 M	76 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
142 M	49.9 M	64.2 M

Cost of Revenue of other stocks in the Medical devices industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
Aethlon Medical AEMD	3.87 M	$ 2.11	8.21 %	$ 3.29 M	USA
AdaptHealth Corp. AHCO	2.64 B	$ 10.42	-1.65 %	$ 1.41 B	USA
Allied Healthcare Products AHPI	24.5 M	-	3.58 %	$ 2.21 M	USA
Acutus Medical AFIB	10.3 M	-	-26.83 %	$ 2.62 M	USA
Alphatec Holdings ATEC	232 M	$ 12.6	2.61 %	$ 1.89 B	USA
Butterfly Network BFLY	33.2 M	$ 3.91	2.62 %	$ 828 M	USA
Cognyte Software Ltd. CGNT	104 M	$ 8.38	-0.24 %	$ 602 M	Israel
Aziyo Biologics AZYO	5.7 M	-	1.37 %	$ 20.5 M	USA
Avinger AVGR	5.65 M	-	-20.74 %	$ 369 K	USA
BIOLASE BIOL	32.4 M	-	-13.19 %	$ 166 K	USA
Boston Scientific Corporation BSX	6.22 B	$ 69.79	0.95 %	$ 103 B	USA
Conformis CFMS	38.8 M	-	-	$ 16.4 M	USA
EDAP TMS S.A. EDAP	37.6 M	$ 3.96	1.02 %	$ 148 M	France
CONMED Corporation CNMD	624 M	$ 37.41	0.35 %	$ 1.16 B	USA
Apollo Endosurgery APEN	34.4 M	-	-	$ 475 M	USA
Cytosorbents Corporation CTSO	10.5 M	$ 0.65	-8.13 %	$ 35.4 M	USA
Cutera CUTR	171 M	-	-10.19 %	$ 1.99 M	USA
Dynatronics Corporation DYNT	21.4 M	-	14.99 %	$ 929 K	USA
ClearPoint Neuro CLPT	12.3 M	$ 11.03	2.22 %	$ 298 M	USA
Establishment Labs Holdings ESTA	64.8 M	$ 63.48	0.21 %	$ 1.88 B	Costa-rica
Axonics Modulation Technologies AXNX	76 M	-	-	$ 3.31 B	USA
Neovasc NVCN	556 K	-	-	$ 111 M	Canada
InMode Ltd. INMD	79.5 M	$ 13.43	-0.81 %	$ 868 M	Israel
GBS GBS	1.81 M	-	-0.57 %	$ 7.12 M	USA
Abbott Laboratories ABT	19.3 B	$ 109.95	1.8 %	$ 191 B	USA
Delcath Systems DCTH	11.8 M	$ 9.81	3.81 %	$ 351 M	USA
Bio-Rad Laboratories BIO	1.19 B	$ 261.24	-0.59 %	$ 7.37 B	USA
Helius Medical Technologies HSDT	583 K	$ 2.19	3.79 %	$ 1.33 M	USA
Integra LifeSciences Holdings Corporation IART	728 M	$ 9.01	-2.49 %	$ 694 M	USA
AxoGen AXGN	57.9 M	$ 32.84	1.55 %	$ 1.51 B	USA
Align Technology ALGN	1.2 B	$ 169.45	3.18 %	$ 12.7 B	USA
Bruker Corporation BRKR	1.72 B	$ 32.76	-2.93 %	$ 4.88 K	USA
IRIDEX Corporation IRIX	30.1 M	$ 1.33	2.31 %	$ 21.5 M	USA
BioSig Technologies BSGM	57 K	-	37.08 %	$ 85.7 M	USA
Apyx Medical Corporation APYX	19.8 M	$ 3.67	1.1 %	$ 151 M	USA
OrthoPediatrics Corp. KIDS	63.7 M	$ 17.11	-1.16 %	$ 401 M	USA
Integer Holdings Corporation ITGR	1.35 B	$ 84.12	1.34 %	$ 2.92 B	USA
Invacare Corporation IVC	566 M	-	-	$ 24.7 M	USA
Second Sight Medical Products EYES	11.8 M	-	-0.97 %	$ 54.4 M	USA